Mumbai, Nov 25: Dabur India on Tuesday, Nov 25 announced the acquisition of 72.15 per cent stake in Fem Care Pharma Limited (FCPL) a leading player in the women's skin care products in an all-cash deal for Rs 203.7 crore. According to a release issued by Dabur to the BSE on Tuesday, Nov 25, the deal values FCPL at Rs 800 per share, an equity valuation of Rs 282.4 crore and enterprise valuation of Rs 300 crore.
Dabur will make an open offer for an additional 20 per cent stake. FCPL shares closed at Rs 656 on the BSE after hitting a 52-week high of Rs 666 on Tuesday, Nov 25. Dabur Chief Executive Officer (CEO) Sunil Duggal said '' The acquisition brings to Dabur a portfolio of well-known household brands. Fem's brands fit in well with Dabur's future growth plans, both for India and the international markets.'' The company has manufacturing facilities in Nashik (Maharashtra) and Baddi (Himachal Pradesh).